Berke SearchMay 14 minThe Berke Report: Clinical and Commercial Updates for the First Week of May 2023FibroGen Announces Results for MATTERHORN, a Phase 3 Clinical Studyof Roxadustat forthe Treatment of Anemia in Patients with...
Berke SearchApr 176 minThe Berke Report: Clinical and Commercial Updates for Week Four of April 2023Pfizer snags FDA approval for expanded pneumococcal vaccine (pharmamanufacturing) Pfizer announced this week that the FDA has approved...